These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38509655)
21. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers. Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099 [TBL] [Abstract][Full Text] [Related]
22. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization. McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528 [TBL] [Abstract][Full Text] [Related]
23. The epidemiological evidence on the carcinogenicity of beryllium in humans. MacMahon B J Occup Med; 1994 Jan; 36(1):15-24; discussion 25-6. PubMed ID: 8138844 [TBL] [Abstract][Full Text] [Related]
24. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254 [TBL] [Abstract][Full Text] [Related]
25. A mortality study of beryllium workers. Boffetta P; Fordyce TA; Mandel JS Cancer Med; 2016 Dec; 5(12):3596-3605. PubMed ID: 27766788 [TBL] [Abstract][Full Text] [Related]
27. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era. Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695 [TBL] [Abstract][Full Text] [Related]
28. Chronic Beryllium Disease: Update on a Moving Target. MacMurdo MG; Mroz MM; Culver DA; Dweik RA; Maier LA Chest; 2020 Dec; 158(6):2458-2466. PubMed ID: 32768458 [TBL] [Abstract][Full Text] [Related]
29. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort. Schuler CR; Kitt MM; Henneberger PK; Deubner DC; Kreiss K J Occup Environ Med; 2008 Dec; 50(12):1343-50. PubMed ID: 19092488 [TBL] [Abstract][Full Text] [Related]
30. Toxic beryllium: new solutions for a chronic problem. Fields S Environ Health Perspect; 2001 Feb; 109(2):A74-9. PubMed ID: 11266347 [No Abstract] [Full Text] [Related]
31. Chronic beryllium disease: uncommon disease, less common diagnosis. Middleton DC Environ Health Perspect; 1998 Dec; 106(12):765-7. PubMed ID: 9831535 [TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of beryllium sensitized workers from a single employer. Duggal M; Deubner DC; Curtis AM; Cullen MR BMC Public Health; 2010 Jan; 10():5. PubMed ID: 20047684 [TBL] [Abstract][Full Text] [Related]
33. Assessment of the beryllium lymphocyte proliferation test using statistical process control. Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408 [TBL] [Abstract][Full Text] [Related]
34. Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis. Verma DK; Ritchie AC; Shaw ML Occup Med (Lond); 2003 May; 53(3):223-7. PubMed ID: 12724557 [TBL] [Abstract][Full Text] [Related]